Australian elapid snakes are among the most venomous in the world. Their venoms contain multiple components that target blood hemostasis, neuromuscular signaling, and the cardiovascular system. We describe here a comprehensive approach to separation and identification of the venom proteins from 18 of these snake species, representing nine genera. The venom protein components were separated by two-dimensional PAGE and identified using mass spectrometry and de novo peptide sequencing. The venoms are complex mixtures showing up to 200 protein spots varying in size from <7 to over 150 kDa and in pI from 3 to >10. These include many proteins identified previously in Australian snake venoms, homologs identified in other snake species, and some novel proteins. In many cases multiple trains of spots were typically observed in the higher molecular mass range (>20 kDa) (indicative of posttranslational modification). Venom proteins and their posttranslational modifications were characterized using specific antibodies, phosphoprotein-and glycoprotein-specific stains, enzymatic digestion, lectin binding, and antivenom reactivity. In the lower molecular weight range, several proteins were identified, but the predominant species were phospholipase A 2 and ␣-neurotoxins, both represented by different sequence variants. The higher molecular weight range contained proteases, nucleotidases, oxidases, and homologs of mammalian coagulation factors. This information together with the identification of several novel proteins (metalloproteinases, vespryns, phospholipase A 2 inhibitors, protein-disulfide isomerase, 5-nucleotidases, cysteinerich secreted proteins, C-type lectins, and acetylcholinesterases) aids in understanding the lethal mechanisms of elapid snake venoms and represents a valuable resource for future development of novel human therapeutics. 
The venomous land snakes of Australia belong to the Elapidae family that also includes the Afro-Asian cobras, the American coral snakes, the Asian kraits, and the African mambas (1) . The venoms are complex mixtures of proteins and peptides possessing a variety of biological activities, and because the amount of venom injected into an animal that reaches the bloodstream may be minute, venom components must achieve their effects at very low concentrations. The use of snake venom in different pathophysiological conditions has been mentioned in homeopathy and folk medicine for centuries. Recently there have been a number of examples of snake venoms used in the development of novel human therapeutics. These include the antihypertensive drug captopril (2) , modeled from the venom of the Brazilian arrowhead viper (Bothrops jaracusa); the anticoagulant Integrilin (eptifibatide (3)), a heptapeptide derived from a protein found in the venom of the American southeastern pygmy rattlesnake (Sistrurus miliarius barbouri); Ancrod (4), a compound isolated from the venom of the Malaysian pit viper (Agkistrodon rhodostoma) for use in the treatment of heparin-induced thrombocytopenia and stroke; and alfimeprase, a novel fibrinolytic metalloproteinase for thrombolysis derived from southern copperhead snake (Agkistrodon contortrix contortrix) venom (5) . Two venom proteins from the Australian brown snake, Pseudonaja textilis, are currently in development as human therapeutics (QRxPharma). The first is a single agent procoagulant that is a homolog of mammalian Factor Xa prothrombin activator (6) , whereas the other is a plasmin inhibitor, named Textilinin-1, with antihemorrhagic properties (7) .
Although there is much known about the protein compositions of venoms from Asian and American snakes, comparatively little is known of Australian snakes. This is despite the top 10 most toxic snakes (determined by LD 50 (lethal dose in mice to kill 50%)) being Australian elapid snakes (8) . Australian snakes are most closely related to Asian snakes, and although they have significantly higher toxicity, they cause far fewer deaths by envenomation than their Asian counterparts, most likely due to lower population density and more widespread availability of suitable health care in Australia (8) . Proteins and peptides comprise the majority of the dry weight of elapid snake venoms, whereas other components include metallic cations, carbohydrates, nucleosides, biogenic amines, and low levels of free amino acids and lipids (9, 10) . Venoms from Australian elapids can be loosely divided into procoagulant and anticoagulant types. The procoagulant venoms contain serine proteases (prothrombin activators) that cleave prothrombin to produce thrombin in the coagulation cascade resulting in coagulation. Snake venom prothrombin activators are classified into four groups based on functional characteristics, structural properties, and cofactor requirements (11) . Group A and B prothrombin activators are metalloproteinases, whereas Group C and D prothrombin activators are serine proteinases. Some Australian snake venoms are known to contain Group C or Group D prothrombin activators (12) . Group C prothrombin activators resemble the mammalian Factor Xa (FXa) 1 -Factor Va (FVa) complex, whereas Group D activators are structurally and functionally similar to FXa alone (12, 13) . The Group C prothrombin activator from the Australian brown snake, P. textilis, has been extensively studied and named Pseutarin C (14) . The 1461-amino acid FVa-like non-enzymatic subunit of Pseutarin C has been shown to share 50% sequence identity and significant structural homology with human FVa (15) . Another hemostasis-related family of proteins identified in Australian snake venom is the textilinin family of plasmin inhibitors (16) . These 7-kDa proteins share ϳ45% identity with aprotinin, a bovine Kunitz-type serine protease inhibitor that acts on plasmin and kallikrein to reduce blood loss during surgery. Six isoforms of textilinin have been identified in P. textilis venom gland-derived cDNA (7) .
Australian snake venoms are also known to contain PLA 2 s and peptidic neurotoxins (for a review, see Ref. 17) . Australian elapid PLA 2 s have seven conserved disulfide bonds and molecular masses of 13-15 kDa. As well as phospholipase activity, individual PLA 2 s are known to have myotoxic, neurotoxic, and/or anticoagulant activities. The ␣-neurotoxins found in Australian elapids are postsynaptic blocking short or long chain neurotoxins (18, 19) . Short and long chain neurotoxins have similar effects and bind with high affinity to skeletal nicotinic acetylcholine receptors. The short chain neurotoxins have four disulfide bonds and are ϳ60 amino acids in length, whereas the long chain neurotoxins have five disulfide bonds and are ϳ73 amino acids in length. More recently, neurotoxic cysteine-rich secreted proteins (CRISPs) have been identified and characterized from the Australian elapids Pseudechis australis and Pseudechis porphyriacus (20, 21) . These 211-amino acid proteins show the ability to block cyclic nucleotide-gated ion channels involved in signaling from the visual and olfactory systems.
Other proteins known to exist in Australian elapid venoms include L-amino-acid oxidase, nerve growth factor (NGF), and natriuretic peptides. L-Amino-acid oxidase was identified in P. australis venom and in purified form was found to be antibacterial when tested against the important pathogen Aeromonas hydrophila (22) . This protein has also been identified in Viperidae snake venoms. NGF has been identified in multiple Asian and African snake venoms but has been reported only recently as a component of Australian elapid venoms (23) . NGF from Oxyuranus scutellatus venom is glycosylated and shows the ability to induce neurite outgrowth of PC12 cells, a standard assay for NGF activity (23) . Natriuretic peptides from Oxyuranus microlepidotus venom show potent arterial smooth muscle relaxant effects (24) . Natriuretic peptides have been identified and characterized from several Australian elapid venoms and represent the smallest known proteins from these venoms at only 35-39 amino acids (25) . The present study describes a thorough screening and identification of the venom proteins present in 18 Australian elapid snake species representing nine genera of the most venomous snakes on earth. In addition, post-translational modifications such as glycosylation, phosphorylation, and ␥-carboxylation were examined in the venom proteins using specific stains and antibodies. Glycoforms of multiple proteins were identified and characterized using lectin binding specificity. Also antivenom reactivity of venom proteins was examined using tiger snake (Notechis) antivenom raised in horses for clinical use in envenomated people. Many proteins previously unknown in Australian snake venoms were identified based on sequence matches to venom proteins from other snakes. This information sheds light on evolutionary relationships between the different snake species and the clinical manifestations of envenomation. This comprehensive proteomics analysis brings Australian elapid snakes in line with their well studied American and Asian counterparts and represents a valuable resource for the future development of novel human therapeutics.
EXPERIMENTAL PROCEDURES
Materials: Snake Venoms and Chemicals-Venom samples from the 18 snake species (Table I) were obtained in lyophilized form from Venom Supplies Pty. Ltd. (Tanunda, South Australia, Australia). Venom samples were collected over the course of a year and pooled from at least 10 snakes from each species to reduce seasonal and individual variation. Lyophilized venom samples were resuspended in 50% glycerol, 50% PBS to a final protein concentration of 10 mg/ml. Water was prepared using a Milli-Q system (Millipore, Bedford, MA). FITC-labeled lectins were from Vector Laboratories (Burlingame, CA). PNGase F and phosphatase (Antarctic phosphatase) were from New England Biolabs (Beverly, MA). Antiserum to P. textilis Factor Xa-like heavy chain antisera was raised in sheep against the purified protein (26). Monoclonal antibody against ␥-carboxyglutamate (Gla) residues was from American Diagnostica Inc. (Greenwich, CT). Tiger snake (Notechis scutatus) antivenom was from Commonwealth Serum Laboratories Ltd. (Victoria, Australia). All other chemicals were from Sigma unless stated otherwise.
Electrophoresis-Prior to the first dimension IEF, 30 l (300 g total) of reconstituted venom was added to 170 l of rehydration solution containing 7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 10 mM DTT, and 0.2% (v/v) pH 3-10 Biolyte ampholytes (Bio-Rad). The final volume of 200 l was applied to a precast Bio-Rad 11-cm pH 3-10 linear IPG strip. First dimension IEF was carried out in a Bio-Rad Protean isoelectric focusing unit at 20°C using a three-phase program: 250-V rapid gradient for 15 min, 250 -8000-V linear gradient for 3 h, and 8000-V rapid gradient to a total of 40,000 V-h. Prior to the second dimension, the proteins in the IPG strips were reduced and alkylated by sequential 15-min incubations in a solution containing 0.05 M Tris-HCl, pH 8.8, 6 M urea, 2% (w/v) SDS, 20% (v/v) glycerol, and (i) 10 mM DTT in 100 mM ammonium bicarbonate for reduction and (ii) 55 mM iodoacetamide in 100 mM ammonium bicarbonate for alkylation. IPG strips were then applied to 12% Tris-HCl acrylamide gels (Bio-Rad Criterion, 13 ϫ 10 cm) for second dimension electrophoresis at 200 V for 65 min. Gels were stained with a mass spectrometry-compatible silver stain based on a method described previously (27) .
Identification of Venom Components and de Novo Sequencing Using MALDI-TOF Mass Spectrometry-Protein spots from silverstained 2D PAGE were excised, washed in water, and destained as described previously (28) . Trypsin was added, and proteins were allowed to digest overnight at 37°C prior to extraction. Extracted peptides were dried; resuspended in 50% ACN, 0.1% TFA; mixed 1:1 with matrix (10 mg/ml ␣-cyano-4-hydroxycinamic acid in 60% acetonitrile, 25 January 11, 2006) . In both cases, mass tolerance was set at 150 ppm. All searches took into account carbamidomethylated cysteine and oxidized methionine. For the purposes of protein identification, no other post-translational modifications were considered, and the top matched protein from the database searches was included in Supplemental Table 1 . The scores used to evaluate the quality of matches for MS/MS data appear in Supplemental Table 1 in columns titled "Ion Score" and "Ion Score confidence interval" calculated by the Mascot search engine. Protein and ion scores increase where the experimental fragmentation data matches theoretical fragmentation data. With regard to acceptance criteria for protein identification, those candidates with Mascot scores greater than the 95% confidence threshold (generally a protein score of 65) and whose protein mass and pI correlated with the 2D PAGE spot were automatically accepted. Those candidates with Mascot scores below the 95% confidence threshold but whose identity matched to a known snake venom protein were also included. Candidates still unknown were selected for de novo peptide sequencing.
For de novo peptide sequencing, MALDI-TOF/TOF MS/MS data were opened in Data Explorer (Applied Biosystems, Version 4.2) and deisotoped, and raw text peak lists were exported. The peak lists were analyzed using the automatic de novo function of PEAKS Studio software Version 2.4 (29) (Bioinformatics Solutions Inc., Ontario, Canada). Peptide sequences of 6 or more amino acids with a 100% confidence call using parent ion and fragment mass error tolerances of 0.1 Da were collected and matched to the NCBI non-redundant protein database using the protein Basic Local Alignment Search Tool (BLAST) algorithm (Version 2.2.14, www.ncbi.nlm.nih.gov/BLAST/).
Enzymatic Deglycosylation-Venom samples (50 g) were precipitated in 8:1 acetone:methanol for 16 h at Ϫ20°C. Samples were centrifuged for 30 min at 16000 ϫ g and 4°C to pellet protein. The supernatants were removed and discarded, and the protein pellets were allowed to air dry for 10 min under ambient conditions. PNGase F (New England Biolabs) was subsequently used according to the manufacturer's instructions. Reactions were allowed to proceed for 16 h at 37°C.
Lectin Binding Specificity-Venom samples (100 g) were separated by 1D PAGE as described above and transferred onto nitrocellulose membrane in Towbin buffer at 100 V for 1 h. Glycosylation profiles of the venom proteins were examined using a panel of eight lectins labeled with FITC (Fluorescein Lectin Kit 1, Vector Laboratories) as described previously (30) .
Phosphoprotein and Glycoprotein Staining-Detection of phosphoproteins and glycoproteins in 1D PAGE was performed using the ProQ Diamond and ProQ Emerald fluorescent reagents, respectively (Molecular Probes, Invitrogen) according to the manufacturer's instructions. ProQ Emerald is a fluorescent form of the periodic acidSchiff stain for carbohydrates that has a broad range of specificity for glycol containing molecules.
Immunoblotting and Antivenom Reactivity-Immunoblotting for Gla residues and the heavy chain of the FXa-like protease was performed as described previously (31) . Tiger snake antivenom reactivity was performed similarly to immunoblotting as follows. Proteins were separated by 1D SDS-PAGE, transferred to nitrocellulose membrane, blocked in 5% skim milk, and incubated overnight in a 1:2000 dilution of antivenom in PBS with 0.05% Tween 20. After extensive washing, the membrane was incubated in a 1:2000 dilution of goat anti-horse Ig conjugated to horseradish peroxidase, and signal was detected using ECL reagent.
RESULTS

Separation and Comparative Analysis of Venom Proteins from 18 Australian Elapid Snake Species
Protein components of the venoms from the 18 species listed in Table I were initially separated by 1D SDS-PAGE and subsequently silver-stained ( Fig. 1) . A similarity of protein bands between individual species within a single genus was apparent. For example, a prominent band of 30 -35 kDa corresponding in size to the heavy chain of FXa-like protease was observed in several venoms including the Notechis (lanes 1-3), Pseudonaja (lanes 4 -6), and Oxyuranus (lanes 14 and 15) species. In addition, several venoms showed significant staining of proteins primarily between 13 and 15 kDa, which is consistent with the size of PLA 2 isoforms known to be abundant in elapid snake venoms. Moreover the multiplicity of bands between 10 and 170 kDa for all species highlights the complexity of these venoms and necessitated the use of 2D PAGE to achieve resolution of individual protein isoforms.
The results in Fig. 2 show representative 2D PAGE silverstained maps for a single species from all nine genera with resolution of proteins in the size range of 6 -160 kDa over a pI range of 3-10. Between 100 and 200 individual protein spots were resolved in the different maps. Horizontal trains of spots are apparent in the upper region of the 2D PAGE maps consistent with multiple isoforms of individual proteins. This phenomenon has been observed previously in 2D PAGE of venom proteins from other snake species (32, 33) . Although up to 200 spots were resolved on each gel, only a limited number of protein families appeared to be present. The 2D PAGE maps for all 18 species without annotation appear in Supplemental Fig. 1 , A-R, and with annotation in Supplemental Fig. 2 , A-R. The mass spectrometry data corresponding to each identified protein spot appear in Supplemental Table 1 .
Comparison of the distinct protein spots on the maps showed features characteristic of species within the same genera. For example, comparison of the four Pseudechis species showed a high degree of similarity between P. australis, Pseudechis guttatus, and Pseudechis colletti. Although most of the protein families present in these three species also appear to be represented in the fourth member of this group, P. porphyriacus, it is evident that the protein pI values have a different pattern of distribution across the range of separation. It is also notable that P. porphyriacus is the only member of this genus known to have procoagulant activity, and the data described here point to additional variation at the protein level (8) .
Identification of Proteins by Mass Spectrometry
Approximately 60 spots were selected from 2D PAGE for each species across a range of molecular sizes and pI values for further analysis. Gel spots were excised and digested with trypsin, and peptides were collected for analysis by MALDI-TOF, MALDI-TOF PSD, and MALDI-TOF/TOF MS/MS. The mass spectra were matched to the NCBI non-redundant or Celera databases to identify the protein spots using the Mascot search engine. Spectra for those spots that were not identified by this approach were subjected to de novo peptide sequence analysis using the PEAKS software package (Bioinformatics Solutions Inc.). The de novo peptide sequences were used in homology searches using the NCBI protein BLAST facility (www.ncbi.nlm.nih.gov/BLAST/). Using this combined approach, between 24 and 51 spots for each species were confidently identified, representing a total of 17 different protein families (Table II) . A number of protein spots were not identified using the above approach possibly because the peptide sequences derived were not sufficiently homologous to those in the sequence databases searched.
A total of 724 protein identifications were made, and a complete list of these together with their protein and ion scores appears in Supplemental Table 1 . Various combinations of the different protein families were present in the 18 species within the nine genera studied (Table II) . Supplemental Fig. 3 contains annotated fragmentation spectra for those 131 of 724 (18.1%) protein identifications based on a single peptide. Supplemental Fig. 4 contains annotated MALDI-TOF spectra for the 34 of 724 (4.7%) protein identifications based on peptide mass mapping (PMM). In some of the PMM spectra several major peaks were not matched suggesting either more than one protein in the spot or incomplete homology with database entries. Although a range of protein and ion scores were obtained in the mass spectrometry analysis, overall the data provided a high level of confidence that the identifications were correct. This was evident by the generally high protein and ion scores for the PMM and MS/MS data as well as high levels of sequence homology in the protein BLAST results from de novo peptide sequencing where the former approach failed to identify the protein. Identities and characteristics of the 17 protein families are provided below.
PLA 2 s and PLA 2 Inhibitors-The most frequently encountered proteins identified across the species were PLA 2 s that were found in all 18 venoms. In all cases there were multiple PLA 2 isoforms representing sequence variants. Because of the large number of isoforms and associated activities for these proteins, information on the specific PLA 2 s identified within the different species can be accessed through the NCBI accession numbers provided in Supplemental Table 1 . In the majority of cases the PLA 2 isoforms were in the molecular size range of 13-17 kDa as predicted from published data and in some cases their cDNA sequences (34) . However, in other cases (for example Acanthophis, Fig. 2F ) there was considerable size variation with PLA 2 s ranging from 13 to 30 kDa. Surprisingly we also detected a protein homologous to the ␣ isoform of PLA 2 inhibitor (35) (NCBI accession number CAB56615) in both Pseudonaja nuchalis and O. microlepidotus. This is the first description of a PLA 2 inhibitor in the Table 1. venom of any snake. Previous reports have demonstrated that PLA 2 inhibitors are present in the blood of Elapidae, Hydrophidae, Boidae, and Colubridae genera, and it was assumed that they were present to provide protection against any PLA 2 s appearing inadvertently in the blood (for a review, see Ref. 36) .
Neurotoxins and Protease Inhibitors-Australian snake venoms are known to contain a multitude of neurotoxins including short and long chain ␣-neurotoxins and neurotoxic PLA 2 s (8). Long chain neurotoxins were found in the majority of venoms. These were readily identifiable in all species of Notechis and Pseudonaja but only in one (P. australis) of the Pseudechis species. On the other hand, short chain neurotoxins were only detected in three species (Table II) . The Kunitz-type serine protease inhibitor textilinin was identified in all species of the Pseudonaja genus as expected. We have previously identified multiple forms of textilinin both at the protein and cDNA level in P. textilis (7, 16) . Proteins with homology to textilinin were also found in the Notechis, Acanthophis, Pseudechis, Tropidechis, and Oxyuranus genera. This molecule is an antifibrinolytic agent that inhibits plasmin (7) .
Prothrombin Activators-Another snake protein known to affect hemostasis is the FXa-like prothrombin activator previously identified in Pseudonaja and other genera (37) . The heavy chain of this protein was identified in all the Notechis, Oxyuranus, and Pseudonaja species along with Tropidechis carinatus, Hoplocephalus stephensii, Rhinoplocephalus nigrescens, and P. porphyriacus. This is consistent with the presence of procoagulant activity in all of these snakes (8) . The heavy chain was identified as a train of spots at ϳ35 kDa and with pI generally ranging from 6 to 9. This peptide was not found in the Austrelaps or other three Pseudechis species or in Acanthophis antarcticus. This is in accordance with previous data showing that these snakes possess largely anticoagulant venoms (8) . In addition, the light chain of the FXa-like molecule is known to contain Gla residues, and immunoblotting with Gla-specific antibody (Fig. 3A) showed reactivity only to species where the heavy chain was also identified by 2D PAGE and MS. It is also notable that the light chain was only identified by mass spectrometry in three species. This is in agreement with previous data where it has been difficult to detect the presence of this peptide by both Coomassie Blue and silver staining (31) . The non-enzymatic cofactor of the prothrombin activator, FVa-like protein, was identified only in Pseudonaja and Oxyuranus, the only two genera known to contain a complete prothrombin activator (15, 37) .
Vespryns-Using MS-based peptide sequencing we identified two peptides in a T. carinatus 2D PAGE protein spot (Supplemental Fig. 2P, spot 14) that showed homology to Ohanin, recently described for the first time in Ophiophagus hannah (king cobra) venom (38) . Ohanin is the first of a new family of proteins named as vespryns. The peptides identified in T. carinatus covered 21 of the 109 residues (19%) of the mature O. hannah protein, and both peptides were located near the center of the protein. Primers were designed based on the full-length O. hannah mRNA sequence (NCBI acces- sion number AY351433) and were used to amplify the fulllength cDNA from venom gland RNA from T. carinatus and several of the other species. 2 The presence of RNA transcripts in elapid venom glands other than T. carinatus suggests the presence of the protein in these venoms; however, no other protein spots in any of the other 17 venoms were identified as vespryns.
Metalloproteinases-In the higher molecular size region, seven of the 18 2D PAGE maps (39%), proteins were matched via MS to proteins homologous to snake venom metalloproteinases (SVMPs). These proteins have been observed in abundance in venoms of viper snakes and also in some elapids (39, 40) . The peptides observed identified the Australian elapid metalloproteinases as PIII type SVMPs that contain a reprolysin zinc metalloprotease domain, a disintegrin domain, and a C-terminal cysteine-rich domain.
C-type Lectins-Protein spots of ϳ15 kDa from six of the 2D PAGE maps were matched via MS to a C-type lectin from Bungarussp.venom.C-typelectinsarenon-enzymatic,calciumdependent, sugar-binding proteins and have been identified previously in several Viperidae and a limited number of Elapidae venoms.
Other Protein Families-Acetylcholinesterase, NGF, 5Ј-nucleotidase, CRISP, L-amino-acid oxidase, protein-disulfide isomerase, and glucose-regulated protein 78 (GRP78) were also isolated in 2D PAGE maps of some of the venoms. Acetylcholinesterase has been characterized previously from Bungarus fasciatus venom (41) and in this study matched to a 70-kDa series of spots spanning ϳ2 pI units in five venoms (A. antarcticus, Notechis ater niger, N. scutatus, Austrelaps superbus, and P. australis). NGF has been identified recently as a component of six Australian elapid venoms (23) and in this study was identified in a further six snakes. 5Ј-Nucleotidase activity has been demonstrated in a variety of snake venoms, including the Australian elapids (42) . In support of these data, protein spots matching to mammalian 5Ј-nucleotidase were observed in seven different venoms including the Oxyuranus species. 2D gel spots corresponding to CRISPs were identified in four venoms. L-Amino-acid oxidase has been identified previously in P. australis venom and in this study was identified in 12 Australian elapid venoms, including P. australis. Protein-disulfide isomerase was identified in P. nuchalis (Western brown snake). Two discrete spots of ϳ50 kDa in the PAGE separation of the venom of Notechis ater serventyi (Supplemental Fig. 2C , spots 19 and 38) were matched via MS to GRP78. This protein has also been identified recently in the venom of another Australian elapid, P. textilis (31) .
Post-translational Modification of Venom Proteins
We have shown previously that 2D PAGE separation of P. textilis venom proteins gives rise to multiple horizontal trains of spots for several proteins, representing differing numbers of charged groups attached post-translationally (31). This phenomenon was evident in the 2D maps for all 18 species of snake venoms in the current study. A clear example of this was observed for the heavy chain of FXa-like protease (35 kDa) present in the three Notechis species (Supplemental Fig.  1, A-C) , the three Pseudonaja species (Supplemental Fig. 1 , D-F), P. porphyriacus (Supplemental Fig. 1K) , and the two Oxyuranus species (Supplemental Fig. 1, N and O) . In N. scutatus, this heavy chain was observed as spots ranging in pI from 8 to 10 (Supplemental Fig. 2A, spots 26 -28) , whereas the predicted pI from the cDNA sequence (NCBI accession number AAX37262) is 8.7. This suggests modifications are added to the heavy chain isoforms resulting in both loss and gain of charge with only minor influence on molecular size.
FIG. 3. Post-translational modifications observed in the 18 venoms.
A, 100 g of crude venoms were separated by 12% SDS-PAGE, transferred to nitrocellulose, and immunoblotted using antibody to Gla residues. B and C, 100 g of crude venoms were separated by 12% SDS-PAGE, and the gels were subsequently stained with ProQ Diamond phosphoprotein-specific stain (B) or with ProQ Emerald glycoprotein-specific stain (C).
Diversity in Australian Snake Venoms
Virtually all the proteins above 30 kDa in all 18 species were represented by multiple horizontal trains of spots.
Although a number of different post-translational modifications have been reported for snake venom proteins (33) , no evidence has been presented for changes in phosphorylation status. Mammalian FVa has been shown to be phosphorylated on Ser-692, which may be important for its inactivation by activated protein C (43). This site is not present in the FVa-like molecule from P. textilis, but Rao et al. (15) have described several predicted phosphorylation sites in this molecule. In an effort to establish the phosphorylation status of venom proteins in all 18 species we used the ProQ Diamond stain, which has been reported to be specific for phosphoproteins (44) . The results in Fig. 3B reveal the presence of strongly staining phosphorylated proteins over a wide range of molecular sizes in seven of the nine genera studied. Acanthophis and Oxyuranus displayed only low intensity staining. Curiously there was a wide range of staining intensity of protein bands within genera as clearly demonstrated by the variation among the three Notechis species (Fig. 3B, lanes 1-3) . The lack of signal in the case of N. ater niger (Fig. 3B, lane 2) is not due to lower protein loading as the same amount of protein was used as in Fig. 1 where the silver-stained gel shows equal loading. No phosphorylation was detected for FXa-like protease heavy and light chains, which are present in abundance in Notechis, Pseudonaja, Oxyuranus, and other species. The identity of these phosphorylated proteins remains to be determined.
Glycoproteins were also detected using the specific stain ProQ Emerald (Fig. 3C) . Glycosylation of a high molecular weight region corresponding in size to the FVa-like protein was particularly prominent for all three Pseudonaja species. Some labeling was also seen for the Oxyuranus species, which also contain Factor Va-like protein. As expected, neither the Notechis, P. porphyriacus, T. carinatus, R. nigrescens, nor H. stephensii had evidence of glycosylation in the high molecular weight region. Although all of these have prothrombinase activity and possess an FXa-like protease they do not have the FVa molecule.
The rather extensive amount of phosphorylation observed in the Notechis and other species such as T. carinatus could mean direct phosphorylation of serine, threonine, and/or tyrosine residues on the protein or the presence of phosphorylated glycan groups on glycoproteins. Accordingly we treated crude venom from these snakes with either deglycosylase (PNGase F) or phosphatase. A Coomassie-stained gel showed that deglycosylation significantly altered the pattern of protein migration (Fig. 4A, lanes 2, 5, 8, and 11) , whereas phosphatase treatment (lanes 3, 6, 9, and 12) showed no discernible effect. Staining for phosphorylated proteins with ProQ Diamond revealed the same degree of loss of phosphate groups after treatment with either deglycosylase or phosphatase (Fig. 4B) , suggesting that the phosphate groups were attached to the glycans rather than directly to the protein. The prominent band at ϳ35 kDa lost its ProQ Diamond reactivity for both N. scutatus and N. ater serventyi crude venoms after treatment with deglycosylase and phosphatase (Fig. 4B, arrow) . We demonstrated that this band corresponds to the heavy chain of the FXa-like molecule by immunoblotting and showed that glycosidase treatment generated two discrete bands, one corresponding to the native protein (30 kDa) and a second band (27 kDa) corresponding to the calculated mass of the native protein (Fig. 4C) . The existence of the upper 30-kDa band suggests incomplete deglycosylation. Although only two species of the FXa-like protease heavy chain were detected on the 1D gels, up to seven discrete spots corresponding to this protein were resolved by 2D PAGE. Immunoblotting with an antivenom against N. scutatus venom also detected these two bands in a region corresponding to the FXa-like heavy chain (Fig. 4D) . There was also evidence of cleavage of additional proteins of higher molecular size. It is of interest that this antivenom also detected a similar distribution and cleavage pattern of proteins in the other two Notechis species as well as T. carinatus (Fig. 4D) . The strong reactivity of the antivenom in the low molecular size region corresponding to neurotoxins is consistent with the reported ability of this antivenom to neutralize neurotoxin activity (45) .
We have shown previously that fluorescently labeled lectins detect a variety of glycoprotein moieties in venom proteins from P. textilis (31) . Using similar methodology, we studied the binding of eight different lectins to proteins separated from all 18 venoms by 1D SDS-PAGE (Fig. 5) . Wheat germ agglutinin (WGA), which binds to N-acetylglucosamine (GlcNAc) and sialic acid, detected a protein band of 13-15 kDa corresponding to the abundant PLA 2 s (Fig. 5A ) in most species except for T. carinatus, R. nigrescens, H. stephensii, and one of the three Pseudonaja species, Pseudonaja affinis. This is consistent with an earlier report showing GlcNAc attached to a PLA 2 from O. scutellatus (46) . There was very prominent staining of a protein of lower molecular size corresponding to the Kunitzlike serine protease inhibitors in three of the 18 species, two of the three Pseudonaja (again not evident in P. affinis) and A. antarcticus. A similar pattern of staining in this molecular size region was also evident in the same species using ConA (mannose and glucose), SNA (sialic acid), Dolichos biflorus agglutinin (N-acetylgalactosamine), UEA (fucose), soybean agglutinin (N-acetylgalactosamine and galactose), RCA120 (N-acetylgalactosamine and galactose), and peanut agglutinin (galactose) binding. However in the case of ConA binding, more prominent labeling was observed for T. carinatus, R. nigrescens, and H. stephensii. A prominent binding band at ϳ22 kDa was detected by SNA and UEA (Fig. 5, C and E) that detect sialic acid or one of its constituents. Although this band is in a region corresponding to the light chain of the FXa-like protease, it is unlikely that this protein has been modified because it was detected in several species that do not have a prothrombin activator. Lectin binding in the high molecular weight region was prominent for WGA and ConA for the vast majority of the 18 species, whereas very little reactivity was seen in this region for the other six lectins. However, there was some reactivity seen with RCA120 (N-acetylgalactosamine and galactose) in a few species.
DISCUSSION
This study represents the first thorough proteomics study of the venoms from the major species of Australian elapid snakes. In all, we identified members of 17 different protein families in nine different genera. The relative lack of complexity allowed us via MS to identify the majority of the proteins separated by 2D PAGE. Proteins were isolated with isoelectric points from 3 to 10 and with molecular sizes ranging from 5 up to 160 kDa. It was evident that there were conserved patterns of protein staining within genera. The most obvious example of this was for the prothrombin activator, which is present in Notechis, Pseudonaja, Oxyuranus, only one of the Pseudechis species, T. carinatus, R. nigrescens, and H. stephensii. Coagulopathy is thought to represent the major cause of morbidity in individuals envenomated by these snakes (8) . In the case of Pseudonaja, all three species had bands that corresponded to components of the prothrombin activator: FValike protein (at 160 kDa), the heavy chain of FXa-like protein (at 35 kDa), and the light chain of the FXa-like protein (at 24 kDa). This was verified by both mass spectrometry and use of specific antisera. These proteins were also evident in the two Oxyuranus species but were present in lesser amount than in the Pseudonaja species as observed previously (47) . St Pierre et al. (47) used comparative analysis of cDNA clones to reveal a three-way identity of 91% at the amino acid level of FXa-like protein between the two Oxyuranus species and P. textilis. In P. textilis, the prothrombin activator (complex of FXa-like and FVa-like) represents up to 30% of the dry weight of the venom (6) . Although the Notechis species also contain procoagulant activity, the FVa-like, non-enzymatic component of the activator is absent. However, the amount of the FXa-like protease in these species was similar to that observed in Pseudonaja. in A and B, lanes 3, 6, 9 , and 12, is the Antarctic phosphatase.
The size difference between this protein band between the two genera can be explained by the presence of an additional 14 amino acids in the Pseudonaja species (47) .
Using mass spectrometry, we identified multiple isoforms of PLA 2 s in all of the Australian elapid venoms. Snake venom PLA 2 s have been implicated in a number of physiological processes including hemorrhage, myotoxicity, hemolytic and hypotensive activities as well as edema, platelet aggregation, cardiotoxicity, and pre-and postsynaptic neurotoxicity (48) . These proteins have been identified in almost all snake venoms, regardless of genera, and it is the PLA 2 enzymes of the Australian elapids that constitute the single most widely studied family of toxins from these snakes (49) . Consequently protein sequence data for these enzymes is readily accessible for PMM matching. Multiple protein spots corresponding to these enzymes were detected across the entire pI range of 3-10 and generally in the molecular size region of 13-15 kDa. Previous evidence from Australian elapids, including P. australis, N. scutatus, and A. superbus, indicates that there are multiple PLA 2 isoforms within the venom of these snakes (50, 51) . A more recent study using cDNA cloning in O. scutellatus identified eight clones coding for PLA 2 sequence variants with predicted mature protein sizes ranging from 13.3 to 14.4 kDa and ranging in pI values from 4.6 to 8.4 (34) , whereas in the present study, PLA 2 s ranged in size from 13 to 50 kDa and in pI values from 3 to 10.
The PMM and MS/MS data obtained here (Supplemental Table 1 ) represents a large number of individual peptides that correspond to a variety of individual PLA 2 s, consistent with previous data that provide evidence for multiple variants of these enzymes (46) . A number of larger molecular size spots from 2D PAGE also contained PLA 2 peptides. However this may be due to incomplete dissociation of molecular complexes during the 2D PAGE procedure, the existence of novel higher molecular size forms, and/or post-translational modifications such as glycosylation as suggested by the lectin binding experiments (Fig. 5 ). An example of this is the Taipoxin complex, a potently active toxin complex within the venom of O. scutellatus composed of three PLA 2 chains: ␣, ␤, and a glycosylated ␥-chain (46). The ␥-chain has a predicted molecular size of 14.6 kDa (Swiss-Prot accession number P00616) yet it migrates to ϳ25 kDa on 2D PAGE (Supplemental Fig. 2, spots 1 and 2 ) likely due to the existence of N-linked carbohydrate structure (46) . The ␥-chain has been observed previously to migrate at 26.9 kDa and has a predicted pI of 4.1, which is consistent with that observed on the 2D PAGE (Supplemental Fig. 2N, spots 1 and 2) . Natriuretic peptides were the only known protein family not found in the present study possibly due to their small molecular size (35-39 amino acids) (25) .
Novel Snake Venom Proteins-In this study we identified two novel proteins, protein-disulfide isomerase (PDI) and a PLA 2 inhibitor not previously reported in the venom of any snake. PDIs are multidomain, multifunctional members of the thioredoxin superfamily that catalyze thiol oxidation, disulfide reduction, and isomerization (52) . Isomerization occurs directly by intramolecular disulfide rearrangement or through cycles of reduction and oxidation (53) . Twelve peptides corresponding to a PDI sequence in the NCBI protein database were identified in a protein spot from P. nuchalis whose molecular size corresponds with the predicted size of the mature protein (58 kDa). The database sequence represents a conceptual translation of a cDNA sequence isolated from the venom gland of O. scutellatus (NCBI accession number AAY33972) and has not yet been published. 3 Because several of the toxic components of the venom are known to contain essential disulfide bridges (e.g. PLA 2 s, textilinins, and prothrombin activator components), it is possible that PDI plays a role in the synthesis and maintenance of these proteins in their active structures in the venom gland. Interestingly human protein-disulfide isomerase has been shown recently to suppress tissue factor coagulant activity by targeting a disulfide bond in tissue factor that is critical for its coagulation activity (54) . This suggests that protein-disulfide isomerase could also play a role as an anticoagulant in the venom.
The second protein, PLA 2 inhibitor, has not been described in snake venom, but there are several reports of the existence of such an inhibitor in the blood of American, Asian, and Australian snakes (35, 55 2 inhibitors exist in snake blood as a defense mechanism against the toxic PLA 2 enzymes produced in the venom glands. We were therefore surprised to find the protein in the venom of P. nuchalis. Three spots were identified corresponding to two forms of the ␣-chain and one of the ␤-chain suggesting that it is closely related, if not identical, to the serum inhibitor. It is not immediately clear why a PLA 2 inhibitor would be present in the venom particularly in such low abundance compared with PLA 2 s themselves. However, because not all snake venom PLA 2 enzymes have PLA 2 activity, it is possible that the inhibitor is specific for only a subclass that could damage the epithelial lining of the venom gland where they are produced. It would seem unlikely that the PLA 2 inhibitor that we identified was the result of serum contamination of the venom sample as no other serum proteins were detected in this or any other venom sample.
Novel Proteins in Australian Snake Venoms-Four families of proteins (vespryn, metalloproteinase, C-type lectin, and acetylcholinesterase) that have been detected previously in snake venoms from other regions are reported here for the first time in venoms of Australian elapids. Pung et al. (38) first described Ohanin as a novel protein from O. hannah (king cobra) venom and subsequently named this protein subfamily "vespryns" (56) . They cloned a full-length cDNA for this protein of 1558 bp. The predicted protein contained a propeptide of 22 amino acids at the N terminus and an additional "propeptide" of 63 amino acids at the C terminus. The mature protein was 107 amino acids in length. It was not clear from the report of Pung et al. (56) how the C-terminal region was identified as a propeptide. Ohanins are related in sequence to PRY-SPRY (B30.2-like) domain-containing proteins that include mammalian ryanodine receptor subtypes and the dual specificity kinase, splA, found in Dictyostelium discoideum. There are only three protein sequences in the public domain with Ͼ50% shared identity to Ohanin. These related proteins are Thaicobrin from Naja kaouthia (UniProt accession number P82885), an Ohanin-like protein from Lachesis muta (GenBank TM accession number DQ396476), and vespryn-POGU1 from the Australian bearded dragon, Pogona barbata (GenBank accession number AAZ75637) (57). Indeed Fry et al. (57) used cDNA libraries and phylogenetic analysis of transcripts such as vespryn-POGU1 to show that nine toxin types are shared between lizards and snakes, supporting their theory for a single, early origin of the venom system in lizards and snakes.
SVMPs have been identified in some viperid and elapid venoms and are reported to play key roles in the development of such symptoms as hemorrhage, edema, hypotension, hypovolemia, inflammation, and necrosis (39) . SVMPs were found in seven of the 18 species examined here. The molecular size varied from 60 to 80 kDa with pI in the range of 4 -6. The mass spectrometry data matched to snake venom metalloproteinases from the M12B reprolysin subfamily. This subfamily possesses three different domains: the reprolysin catalytic domain, a disintegrin domain that inhibits the binding of ligands to integrin receptors, and a cysteine-rich domain. The peptide sequences identified here were found to match these regions. It is likely that these enzymes are present in most Australian elapid snakes because it was possible to successfully amplify metalloproteinase cDNAs using PCR primers designed from the cobra cDNA sequence (GenBank accession number AY101383) 4 from seven different genera. 2 The presence of these enzymes in a wide variety of snakes suggests that they play important roles in toxicity. SVMPs possess multidomain functions, and it has been shown that the catalytic site is not the only crucial domain enabling this class of toxin to cause hemorrhage and inflammation (58) . This is evidenced by a form of SVMP, jararhagin C, that lacks the catalytic domain yet is capable of activating an acute inflammatory response in a mouse model (58) . Platelets are the main target of these enzymes in the disruption of hemostasis that occurs by inhibition of interaction with collagen and/or von Willebrand factor using various mechanisms that result in systemic bleeding.
C-type lectins were also identified in Australian elapid snake venoms for the first time. These calcium-dependent sugar-binding proteins have been characterized extensively from Viperidae venoms. However, only a limited number of C-lectins have been identified in Elapidae venoms, and these remain to be fully characterized. Viper venom C-lectins have been shown to cause edema and increased vascular permeability and to agglutinate erythrocytes (59, 60) . The C-lectins identified from the Australian elapids match most closely to a galactose-binding C-lectin sequence from the krait B. fasciatus, suggesting that they also bind this sugar. Although this protein was only identified in six of the 18 species, C-lectin cDNAs have been successfully amplified from seven different genera of Australian elapids 5 suggesting that this protein is a common venom component in these snakes.
Acetylcholinesterase activity has been reported in several snake venoms previously; however, only one snake venom acetylcholinesterase has been isolated and characterized, that from B. fasciatus (41) . Acetylcholinesterase was identified via MS in five species as an ϳ80-kDa train of spots. This molecular size is consistent with that of B. fasciatus acetylcholinesterase, which is known to contain N-linked glycosylation. Glycosylation of the Australian forms may account for the train of spots observed in this study.
Post-translational Modifications-We have provided evidence here for at least three types of post-translational modification in the venom proteins from the different genera of the Australian elapids: phosphorylation, glycosylation, and ␥-carboxylation. Only one previous report, from our laboratory, has provided evidence for the presence of phosphorylated snake venom proteins (31) . It seems unlikely that this was artifactual binding because the phosphorylated spots correlated well with protein staining, and the ProQ Diamond technique has been shown to be very specific for protein phosphorylation (44) . This method of staining failed to detect phosphate in DNA or RNA and did not detect sulfated glycans. Birrell et al. (31) demonstrated that ProQ Diamond detected proteins in P. textilis that corresponded in size to the major toxins in that venom including FVa-like and FXa-like proteins as well as PLA 2 s. In this study, phosphorylated proteins were detected in most snake species, and they varied in molecular size from ϳ15 kDa up to greater than 100 kDa. Proteins are normally phosphorylated as parts of signaling mechanisms, leading to alterations in their conformation and/or their capacity to interact with other proteins. In this case it is more likely that the phosphorylated species detected are glycoproteins containing phosphorylated carbohydrate. Phosphorylated glycoproteins are widely distributed in nature and play key roles in a variety of biological processes. For example, soluble lysosomal proteins are synthesized in the endoplasmic reticulum and are cotranslationally glycosylated on specific asparagine residues. As these proteins move through the secretory pathway, they are selectively recognized by a phosphotransferase that initiates a two-step reaction that results in the generation of the mannose 6-phosphate modification on specific N-linked oligosaccharides. This modification causes the lysosomal protein to bind mannose 6-phosphate receptors as part of the process of endocytosis and lysosomal targeting (61) . Another example of a glycoprotein in which the carbohydrate moiety is phosphorylated is cathepsin D (62) . Cathepsin D is an aspartic peptidase that is found at elevated levels in some tumor tissues; however, the role of the phosphorylated carbohydrate is unknown. To understand the role of putative phosphorylated glycoproteins in snake venom it will be necessary to identify these proteins, determine whether phosphorylation status influences their interaction with other proteins, and determine whether phosphorylation alters the function of these proteins in specific functional assays, e.g. proteolytic activity, coagulability, or neurotoxicity.
Glycosylation of proteins was detected using lectin binding and ProQ Emerald staining. A high molecular weight signal was detected in the venom from several species that corresponded to FVa-like protein in 1D SDS-PAGE (Fig. 3C) . This is in good agreement with previous results using 2D PAGE with P. textilis that detected spots of the same molecular size as FVa-like and FXa-like proteins. This was confirmed with ConA (glucose-and mannose-specific) and WGA (GlcNAc-and sialic acid-specific) lectins. It is not evident what role this modification may have on components of the prothrombin activator, but it is possible that the abundance of glycosylation of these proteins influences their stability and/or function. Increased stability would result in greater diffusion and transport of glycosylated toxins upon envenomation.
Clinical Implications-In general, the results of this study support previous clinical data from patients envenomated by Australian elapid species. The major clinical effects of Australian elapid venoms include paralysis, coagulopathy, and muscle destruction, and these symptoms can be attributed largely to three groups of proteins, neurotoxins, prothrombin activators, and PLA 2 s (8). Inspection of the 2D maps showed that these three groups of proteins account for a large proportion of the total venom proteins, confirming their high abundance. We identified several venom proteins not known previously in Australian snake venoms, but reported in other snake venoms, that may have clinical manifestations. For example, SVMPs from several Viperidae venoms can cause hemorrhage, edema, hypotension, hypovolemia, inflammation, and necrosis (39) . Similarly C-type lectins that have also been characterized from Viperidae venoms can cause edema and increased vascular permeability and can agglutinate erythrocytes (59, 60) . Thus it may be possible that some clinical effects attributed previously to PLA 2 s, such as necrosis and inflammation, are in fact caused by the SVMPs. The clinical effects of other proteins identified in Australian elapid snakes for the first time here also remain to be determined. Moreover some of these proteins may have unique activities applicable to the development of new human therapeutics.
Conclusions-We have described here a comprehensive analysis of the venom proteins of 18 Australian elapid snakes that are among the most venomous snakes worldwide. This represents a significant advance in the proteomics of snake venom proteins and an important resource for comparison of protein patterns both between species of the same genera and across genera. The vast majority of these proteins were identified using mass spectrometry of spots isolated from 2D PAGE.
Because a significant number of the peptides isolated failed to match with any peptides in the NCBI non-redundant protein database it was necessary to use de novo peptide sequencing by tandem mass spectrometry, which significantly increased the total number of proteins identified. In all, we identified six previously undescribed families of proteins in Australian elapid snakes. Some of these, including vespryns, metalloproteinases, C-type lectins, and 5Ј-nucleotidase were described previously in non-Australian snake venoms (38, (63) (64) (65) (66) . Protein-disulfide isomerase and PLA 2 inhibitor have not been reported previously in any snake venom, although a very recent report has described a cDNA coding for PDI (67) , and a PLA 2 inhibitor has been reported in snake serum (36) . In addition to identifying all the major venom proteins in the Australian snakes, we partially characterized them using specific antibodies, phosphoprotein-and glycoprotein-specific stains, enzymatic digestion, lectin binding, and antivenom reactivity. Further characterization of these proteins will assist in delineating their role in the venoms, their clinical effects, and their potential as therapeutic agents.
